Abstract A166: BELLE-4: A Phase II study of buparlisib and paclitaxel in women with HER2- advanced breast cancer, with or without PI3K pathway activation
Year: 2015
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Miguel Martín, Arlene Chan, Luc Dirix, Joyce O'Shaughnessy, Roberto Hegg, Alexey Manikhas, Mikhail Shtivelband, Petr Krivorotko, Norberto Batista López, Mario Campone, Manuel Ruiz Borrego, Qamar J. Khan, J. Thaddeus Beck, Manuel Ramos Vasquez, Patrick Urban, Pantelia Roussou, Emmanuelle Di Tomaso, Cristian Massacesi, Suzette Delaloge
Institutions: Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Curtin University, Hospital da Mulher São Paulo, City Clinical Oncology Center, Institute of Oncology NN Petrov, Hospital Universitario de Canarias, Hospital Universitario Virgen del Rocío, University of Kansas Medical Center, Highlands Oncology Group, Centro Oncológico de Galicia, Novartis (Switzerland), Novartis (France), Institut Gustave Roussy
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2397670832